Page 116 - 《中国药房》2024年13期
P. 116
[21] BAKHSHIMOGHADDAM F,SHATERI K,SINA M,et Bifidobacterium longum with fructo-oligosaccharides in
al. Daily consumption of synbiotic yogurt decreases liver patients with non alcoholic steatohepatitis[J]. Dig Dis Sci,
steatosis in patients with nonalcoholic fatty liver disease:a 2012,57(2):545-553.
randomized controlled clinical trial[J]. J Nutr,2018,148 [31] BARCELOS S T A,SILVA-SPERB A S,MORAES H A,
(8):1276-1284. et al. Oral 24-week probiotics supplementation did not de‐
[22] ASGHARIAN A,ASKARI G,ESMAILZADE A,et al. crease cardiovascular risk markers in patients with biopsy
The effect of symbiotic supplementation on liver en‐ proven NASH:a double-blind placebo-controlled rando-
zymes,C-reactive protein and ultrasound findings in pa‐ mized study[J]. Ann Hepatol,2022,27(9):100769.
tients with non-alcoholic fatty liver disease:a clinical trial [32] ESCOUTO G S,PORT G Z,TOVO C V,et al. Probiotic
[J]. Int J Prev Med,2016,7:59. supplementation,hepatic fibrosis,and the microbiota pro‐
[23] EKHLASI G,KOLAHDOUZ MOHAMMADI R,AGAH file in patients with nonalcoholic steatohepatitis:a ran‐
S,et al. Do symbiotic and vitamin E supplementation domized controlled trial[J]. J Nutr,2023,153(7):1984-
have favorite effects in nonalcoholic fatty liver disease:a 1993.
randomized,double-blind,placebo-controlled trial[J]. J [33] ABDEL MONEM S M. Probiotic therapy in patients with
Res Med Sci,2016,21:106. nonalcoholic steatohepatitis in Zagazig University hospi‐
[24] NABAVI S,RAFRAF M,SOMI M H,et al. Effects of tals[J]. Euroasian J Hepatogastroenterol,2017,7(1):
probiotic yogurt consumption on metabolic factors in indi‐ 101-106.
viduals with nonalcoholic fatty liver disease[J]. J Dairy [34] ABHARI K,SAADATI S,YARI Z,et al. The effects of
Sci,2014,97(12):7386-7393. Bacillus coagulans supplementation in patients with non-
[25] ALLER R,DE LUIS D A,IZAOLA O,et al. Effect of a alcoholic fatty liver disease:a randomized,placebo-
probiotic on liver aminotransferases in nonalcoholic fatty controlled,clinical trial[J]. Clin Nutr ESPEN,2020,39:
liver disease patients:a double blind randomized clinical 53-60.
trial[J]. Eur Rev Med Pharmacol Sci,2011,15(9):1090- [35] SALMINEN S,COLLADO M C,ENDO A,et al. The In‐
1095. ternational Scientific Association of Probiotics and Prebi‐
[26] 姜艳艳. 肠道益生菌治疗非酒精性脂肪肝的效果及对肝 otics (ISAPP) consensus statement on the definition and
功能、炎性因子的影响[J]. 临床合理用药杂志,2020,13 scope of postbiotics[J]. Nat Rev Gastroenterol Hepatol,
(8):26-27. 2021,18(9):649-667.
JIANG Y Y. Effect of intestinal probiotics on nonalcoholic [36] MIJANGOS-TREJO A,NUÑO-LAMBARRI N,BARBERO-
fatty liver and its influence on liver function and inflam‐ BECERRA V,et al. Prebiotics and probiotics:therapeutic
matory factors[J]. Chin J Clin Ration Drug Use,2020,13 tools for nonalcoholic fatty liver disease[J]. Int J Mol Sci,
(8):26-27. 2023,24(19):14918.
[27] 郑丹,吴江,甘洪颖,等. 双歧杆菌三联活菌胶囊治疗非 [37] SALTZMAN E T,PALACIOS T,THOMSEN M,et al. In‐
酒精性脂肪肝的临床观察[J]. 临床消化病杂志,2018,30 testinal microbiome shifts,dysbiosis,inflammation,and
(4):240-243. non-alcoholic fatty liver disease[J]. Front Microbiol,
ZHENG D,WU J,GAN H Y,et al. Clinical study of pro‐ 2018,9:61.
biotics for non-alcoholic fatty liver disease[J]. Chin J Clin [38] 高明月,杨雅坤,殷雅楠,等. 肠道菌群介导的非酒精性
Gastroenterol,2018,30(4):240-243. 脂肪性肝病发病机制研究进展[J]. 解放军医学杂志,
[28] 赵庆卫,吕道仙. 益生菌对非酒精性脂肪性肝病的干预 2020,45(9):990-995.
作用[J]. 中国现代医生,2016,54(8):29-33. GAO M Y,YANG Y K,YIN Y N,et al. Research ad‐
ZHAO Q W,LYU D X. Probiotics for non-alcoholic fatty vances in the pathogenesis of non-alcoholic fatty liver me‐
liver disease intervention effect[J]. China Mod Dr,2016, diated by intestinal flora[J]. Med J Chin People’s Libera‐
54(8):29-33. tion Army,2020,45(9):990-995.
[29] JAVADI L,KHOSHBATEN M,SAFAIYAN A,et al. Pro- [39] ZHOU X Y,WANG J C,ZHOU S F,et al. Efficacy of pro‐
and prebiotic effects on oxidative stress and inflammatory biotics on nonalcoholic fatty liver disease:a meta-analysis
markers in non-alcoholic fatty liver disease[J]. Asia Pac J [J]. Medicine (Baltimore),2023,102(4):e32734.
Clin Nutr,2018,27(5):1031-1039. (收稿日期:2023-11-08 修回日期:2024-04-02)
[30] MALAGUARNERA M,VACANTE M,ANTIC T,et al. (编辑:刘明伟)
· 1650 · China Pharmacy 2024 Vol. 35 No. 13 中国药房 2024年第35卷第13期